A bioactive hydrogel regulates chondrocyte fate with hypoxia-mimetic chondrogenic induction and vascular invasion suppression for full-thickness cartilage repair.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42743818.
- Also identified by DOI 10.1016/j.biomaterials.2026.124631.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Chondrogenic differentiation of bone marrow mesenchymal stem cells (BMSCs) is always compromised by hypertrophic maturation, rendering long-term phenotype maintenance a key challenge. While hypoxia drives chondrogenic commitment, sustained hypoxic stimulation within the injured joint paradoxically accelerates hypertrophy via subchondral vascular invasion and inflammatory imbalance. To resolve this dilemma, we developed a photocross-linkable hydrogel composed of N-acryloyl aspartic acid (AASP) and asiatic acid-grafted gelatin (Gel-AA) for full-thickness cartilage repair. Mechanistically, the carboxyl groups of AASP chelate iron ions and stabilize HIF-1α, sustaining its activity under normoxic conditions to establish a hypoxia-mimicking microenvironment that promotes BMSC chondrogenesis. Of note, AA curbs vascular invasion, reduces oxidative stress, and prevents hypertrophic drift by suppressing VEGF-driven angiogenic signaling and reshaping the immune microenvironment toward a regenerative state. Consequently, this hydrogel fine-tunes chondrocyte fate by coupling the initiation of chondrogenic differentiation with the inhibition of subsequent phenotypic deterioration. In vivo results further verified that this dual-regulatory strategy achieves structurally and phenotypically stable hyaline-like cartilage regeneration, offering a promising therapeutic paradigm for cartilage repair.